Neoadjuvant Concomitant Modulated Electro-hyperthermia in HER2-negative Breast Cancer
Clinical trial NCT05889390 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05889390
- Sponsor
- Semmelweis University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-20
- Primary completion
- 2025-10-31
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.